|
Amgen Inc |
|
United States |
+1 (805) 447-1000 |
N/A |
|
|
|
Clarus Ventures II |
Venture capital fund investing in biopharmaceuticals and medical technology |
United States |
|
Series C |
|
|
|
Hatteras Venture Partners III (HVP III) |
|
United States |
+1 (919) 484-0730 |
Series C |
|
|
|
Healthcare Ventures LLC |
Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. |
United States |
+1 (617) 252-4343 |
Series B |
|
|
|
Healthcare Ventures LLC |
Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. |
United States |
+1 (617) 252-4343 |
Series C |
|
|
|
Latterell Venture Partners (LVP) |
|
United States |
+1 (415) 399-9880 |
Series B |
|
|
|
Latterell Venture Partners (LVP) |
|
United States |
+1 (415) 399-9880 |
Series C |
|
|
|
Nextech Invest Ltd (Nextech Venture) |
|
Switzerland |
+41 (1) 366-6611 |
Series C |
|
|
|
Novitas Capital |
|
United States |
|
Series C |
|
|
|
PA Early Stage Partners (Pennsylvania Early Stage Partners) |
|
United States |
|
Series B |
|
|
|
Pfizer Inc |
|
United States |
+1 (212) 733-7034 |
Series C |
|
|
|
Quaker BioVentures Inc |
|
United States |
+1 (215) 988-6800 |
Series B |
|
|
|
Quaker BioVentures Inc |
|
United States |
+1 (215) 988-6800 |
Series C |
|
|
|
The Vertical Group Inc |
|
United States |
+1 (650) 566-9060 |
Series B |
|
|
|
The Vertical Group Inc |
|
United States |
+1 (650) 566-9060 |
Series C |
|
|